FIELD: medicine.
SUBSTANCE: presented is the use of a hexanodium salt of myo-inositol hexaphosphate or a pharmaceutical composition containing said salt together with pharmaceutically acceptable excipients and carriers for treating or preventing peripheral arterial disease.
EFFECT: invention provides improved blood perfusion in extremities and mobility (ability to walk) of patients suffering peripheral artery diseases and critical extremity ischemia.
12 cl, 17 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, DELAYING PROGRESSION OR PREVENTING CARDIOVASCULAR CALCIFICATION | 2020 |
|
RU2832087C1 |
| USE OF DERIVATIVES CONTAINING THE C-O-P BONDS IN THE PATIENTS WITH RENAL INSUFFICIENCY | 2014 |
|
RU2725626C2 |
| DEUTERATED ANALOGUES OF ACETYLEUCINE | 2019 |
|
RU2810793C2 |
| N-HYDROXILSULFONAMIDE DERIVATIVES AS NEW PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2007 |
|
RU2616292C2 |
| N-HYDROXYLSULPHONAMIDE DERIVATIVES AS NOVEL PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2008 |
|
RU2485097C2 |
| N-HYDROXYLSULPHONAMIDE DERIVATIVES AS NOVEL PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2007 |
|
RU2448087C2 |
| COMPOSITIONS AND METHODS OF TREATING GALACTOSEMIA | 2018 |
|
RU2830187C2 |
| COMPOSITION CONTAINING CRYSTALLIZATION INHIBITORS | 2014 |
|
RU2691060C2 |
| 2-PHENYLAMINO-3-CYANOPYRAZOLO[1,5-A]PYRIMIDINE, USEFUL AS INHIBITOR OF LEUKOTRIENE A HYDROLASE | 2014 |
|
RU2678196C2 |
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
